Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FLT3 ( clone FR45YT7). We employs the pUC (CMV-Cy3-PAX-PstI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
FLT3
Clone
FR45YT7
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
PAX
Insertion Sites
PstI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.88
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.